Ventricular Tachycardia Triggered by Loperamide and Famotidine Abuse
Timothy R Larsen1,2, Jedediah McMunn3, Hala Ahmad3
1Carilion Clinic, Virginia Tech Carilion School of Medicine, 2001 Crystal Spring Ave, Suite 203, Roanoke, VA, 24014, USA. Tlarsen17@gmail.com.
Abstract:
A 32-year-old male developed recurrent ventricular tachycardia after taking mega doses of loperamide and famotidine in order to experience an opiate-like euphoric effect. He was taking up to 200 mg of loperamide and multiple doses of famotidine each day. He developed palpitations and syncope. Electrocardiography demonstrated ventricular tachycardia and QT interval prolongation (corrected QT interval was 597 ms). He was diagnosed with loperamide-induced QT prolongation resulting in incessant ventricular tachycardia. Loperamide was discontinued, and he was treated with electrolyte replacement, supportive care, and monitoring. After 5 days, his electrocardiogram (ECG) normalized and he had no more ventricular tachycardia. A Naranjo assessment score of 8 was obtained, indicating a probable relationship between QT prolongation and his use of loperamide. Large doses of loperamide can cause QT interval prolongation and life-threatening arrhythmias. These effects may be accentuated when histamine-2 receptor blockers are also abused.
Related Concept Videos
Drug Abuse and Addiction: Pharmacological Phenomena
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Anatomy of the Heart
Fixed Action Patterns
Intracellular Signaling Cascades
Master Transcription Regulators


